PMID- 27293539
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20160613
LR  - 20220317
IS  - 2042-0188 (Print)
IS  - 2042-0196 (Electronic)
IS  - 2042-0188 (Linking)
VI  - 7
IP  - 3
DP  - 2016 Jun
TI  - Management of diabetes in Morocco: results of the International Diabetes 
      Management Practices Study (IDMPS) - wave 5.
PG  - 101-9
LID - 10.1177/2042018816643227 [doi]
AB  - OBJECTIVES: The International Diabetes Mellitus Practice Study (IDMPS) is a 
      5-year survey documenting changes in diabetes treatment practices in developing 
      countries. The primary objective of this survey was to assess the therapeutic 
      management of type 2 diabetes mellitus (T2DM) in real-life medical practice. The 
      secondary objectives were to evaluate the clinical management of type 1 diabetes 
      mellitus (T1DM) and to assess the proportion of all diabetic patients failing to 
      reach the glycated haemoglobin (HbA1c) <7% target. METHODS: Data were analysed 
      for 738 patients (240 with T1DM and 498 with T2DM) included in wave 5 of the 
      IDMPS in Morocco in 2011. RESULTS: Nearly two-thirds (61%) of T2DM patients were 
      treated with oral glucose-lowering drugs (OGLDs) alone, 13.1% were treated with 
      insulin alone and 23.3% were treated with OGLDs plus insulin. Insulin use was 
      less frequent, was initiated later and involved a greater use of premixes versus 
      basal/prandial schedules compared to other populations evaluated in the IDMPS. 
      The majority (92.5%) of T1DM patients were treated with insulin alone and the 
      remainder received insulin plus an OGLD. Insulin protocols included basal + 
      prandial dosing (37.5%) and premix preparations (41.3%). The recommended target 
      of HbA1c <7% was achieved by only 22.2% of T1DM patients and 26.8% of T2DM 
      patients. More macrovascular but fewer microvascular complications were reported 
      in T2DM compared to T1DM patients. Late complications increased with disease 
      duration so that 20 years after diagnosis, 75.7% of T2DM patients were found to 
      have at least one late complication. CONCLUSIONS: The clinical burden of diabetes 
      is high in Morocco and the majority of patients do not achieve the recommended 
      glycaemia target, suggesting that there is a huge gap between evidence-based 
      diabetic management and real-life practice. Better education of patients and 
      improved compliance with international recommendations are necessary to deliver a 
      better quality of diabetic care.
FAU - Chadli, Asmae
AU  - Chadli A
AD  - Ibn Rushd University Hospital, Casablanca, Morocco.
FAU - El Aziz, Siham
AU  - El Aziz S
AD  - Ibn Rushd University Hospital, Casablanca, Morocco.
FAU - El Ansari, Nawal
AU  - El Ansari N
AD  - Mohammed VI University Hospital, Marrakesh, Morocco.
FAU - Ajdi, Farida
AU  - Ajdi F
AD  - Hassan II University Hospital, Fez, Morocco.
FAU - Seqat, Mehdi
AU  - Seqat M
AD  - Sanofi Maroc, Casablanca, Morocco.
FAU - Latrech, Hanane
AU  - Latrech H
AD  - Mohamed VI University Hospital, Oujda, Morocco.
FAU - Belmejdoub, Ghizlaine
AU  - Belmejdoub G
AD  - Military Hospital Instruction Mohammed V, Rabat, Morocco.
LA  - eng
PT  - Journal Article
DEP - 20160413
PL  - United States
TA  - Ther Adv Endocrinol Metab
JT  - Therapeutic advances in endocrinology and metabolism
JID - 101532143
PMC - PMC4892401
OTO - NOTNLM
OT  - basal-prandial
OT  - complications
OT  - diabetes
OT  - glycaemic control
OT  - insulin
OT  - management
COIS- Conflict of interest statement: The author(s) declared the following potential 
      conflicts of interest with respect to the research, authorship, and/or 
      publication of this article: A. Chadli, S. El Aziz, N. El Ansari, F. Ajdi, H. 
      Latrech and G. Belmejdoub declare that there is no conflict of interest. M. Seqat 
      is an employee of Sanofi-Aventis, Morocco.
EDAT- 2016/06/14 06:00
MHDA- 2016/06/14 06:01
PMCR- 2016/06/01
CRDT- 2016/06/14 06:00
PHST- 2016/06/14 06:00 [entrez]
PHST- 2016/06/14 06:00 [pubmed]
PHST- 2016/06/14 06:01 [medline]
PHST- 2016/06/01 00:00 [pmc-release]
AID - 10.1177_2042018816643227 [pii]
AID - 10.1177/2042018816643227 [doi]
PST - ppublish
SO  - Ther Adv Endocrinol Metab. 2016 Jun;7(3):101-9. doi: 10.1177/2042018816643227. 
      Epub 2016 Apr 13.